262 related articles for article (PubMed ID: 28893110)
1. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
Martins CD; Kramer-Marek G; Oyen WJG
Expert Opin Drug Deliv; 2018 Feb; 15(2):185-196. PubMed ID: 28893110
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on metals-based radioimmunotherapy (RIT): moving forward.
White JM; Escorcia FE; Viola NT
Theranostics; 2021; 11(13):6293-6314. PubMed ID: 33995659
[TBL] [Abstract][Full Text] [Related]
4. Emerging trends for radioimmunotherapy in solid tumors.
Jain M; Gupta S; Kaur S; Ponnusamy MP; Batra SK
Cancer Biother Radiopharm; 2013 Nov; 28(9):639-50. PubMed ID: 23844555
[TBL] [Abstract][Full Text] [Related]
5. Current status and perspectives in alpha radioimmunotherapy.
Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
[TBL] [Abstract][Full Text] [Related]
6. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
7. [Radiolabeled antibodies for cancer treatment].
Barbet J; Chatal JF; Kraeber-Bodéré F
Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Eugène T; Pallardy A; Frampas E; Carlier T; Ferrer L; Gaschet J; Davodeau F; Gestin JF; Faivre-Chauvet A; Barbet J; Chérel M
Semin Oncol; 2014 Oct; 41(5):613-22. PubMed ID: 25440606
[TBL] [Abstract][Full Text] [Related]
9. Advances in anticancer radiopharmaceuticals.
Jackson MR; Falzone N; Vallis KA
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):604-9. PubMed ID: 23870756
[TBL] [Abstract][Full Text] [Related]
10. Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy.
Srivastava SC
Cancer Biother Radiopharm; 1996 Feb; 11(1):43-50. PubMed ID: 10851519
[TBL] [Abstract][Full Text] [Related]
11. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy.
Ladjohounlou R; Lozza C; Pichard A; Constanzo J; Karam J; Le Fur P; Deshayes E; Boudousq V; Paillas S; Busson M; Le Blay M; Jarlier M; Marcatili S; Bardiès M; Bruchertseifer F; Morgenstern A; Torgue J; Navarro-Teulon I; Pouget JP
Clin Cancer Res; 2019 Aug; 25(15):4775-4790. PubMed ID: 31061069
[TBL] [Abstract][Full Text] [Related]
12. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
Karagiannis TC
Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
[TBL] [Abstract][Full Text] [Related]
14. Targeted cancer therapy using radiolabeled monoclonal antibodies.
Bethge WA; Sandmaier BM
Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058
[TBL] [Abstract][Full Text] [Related]
15. Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
Cornelissen B; Vallis KA
Curr Drug Discov Technol; 2010 Dec; 7(4):263-79. PubMed ID: 21034408
[TBL] [Abstract][Full Text] [Related]
16. Combination Radioimmunotherapy Strategies for Solid Tumors.
Zaheer J; Kim H; Lee YJ; Kim JS; Lim SM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717302
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
Kawashima H
ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Karagiannis TC
Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
[TBL] [Abstract][Full Text] [Related]
19. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
[TBL] [Abstract][Full Text] [Related]
20. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
